|
0
|
|
alpha-aminobutyric acid promotes tumor progression by polarizing macrophages through the ASNS-mTORC2 axis.
(pnas.org)
|
Li F
…
He R
PNAS
2026-09-30
|
#cancer
#immunotherapy
#macrophage
#metabolism
#polarization
|
|
0
|
|
An enzyme-responsive nanoplatform rewires host-microbe tryptophan metabolism for cancer immunotherapy.
(linkinghub.elsevier.com)
|
Pan C
…
Gan Y
Cell Host & Microbe
2026-09-30
|
#metabolism
#cancer
#immunotherapy
#microbiome
#nanoparticles
|
|
0
|
|
In vivo-edited CCR7(+)IL-7(+) DCs reverse T cell exhaustion by promoting T memory stem cell differentiation.
(linkinghub.elsevier.com)
|
Fu S
…
Zhang N
Cell Reports Medicine
2026-09-30
|
#immunotherapy
#t cell exhaustion
#dendritic cell
#cancer
#memory-stem-cells
|
|
0
|
|
Beyond BMI: The diet-microbiome context of the obesity paradox.
(linkinghub.elsevier.com)
|
Tao EW
…
Chen YX
Cancer Cell
2026-09-30
|
#microbiome
#metabolism
#immunotherapy
#obesity
|
|
0
|
|
A highly potent bispecific antibody confers complete protection against SFTSV in preclinical models.
(pnas.org)
|
Guo X
…
Chiu S
PNAS
2026-09-30
|
#antibody
#neutralization
#immunotherapy
#therapeutics
#bunyavirus
|
|
0
|
|
Long-term clinical and biomarker observations following rituximab exposure in two siblings with CSF1R-related leukoencephalopathy: a preliminary familial case series.
(nature.com)
|
Balevicius R
…
Karrenbauer VD
Communications Medicine
2026-09-30
|
#neurodegeneration
#leukoencephalopathy
#immunotherapy
#biomarker
#microglial
|
|
0
|
|
Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial.
(nature.com)
|
Garcia-Carbonero R
…
Hidalgo M
Nature Medicine
2026-09-30
|
#pancreatic
#oncolytic
#chemotherapy
#virotherapy
#immunotherapy
|
|
0
|
|
Targeting mutant NPM1-expressing AML with T cell receptor-like antibodies.
(linkinghub.elsevier.com)
|
Hong Y
…
Hu J
iScience
2026-09-30
|
#immunotherapy
#leukemia
#antibody
#neoantigen
#cytotoxicity
|
|
0
|
|
IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial.
(nature.com)
|
Tiu C
…
Meier P
Nature Communications
2026-09-30
|
#cancer
#immunotherapy
#apoptosis
#immunogenicity
#checkpoint
|